Trial · NCT01496365
Results by group350
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 350
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline to Week 5 in Average Daily Pain Score (ADPS) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | Placebo | -1.86 | Standard Deviation 2.18 | units on a scale | |
| Mean Change From Baseline to Week 5 in Average Daily Pain Score (ADPS) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | Pregabalin 150 mg BID | -1.79 | Standard Deviation 2.27 | units on a scale | |
| Mean Change From Baseline to Week 5 in Average Daily Pain Score (ADPS) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 5mg QD | -2.04 | Standard Deviation 2.22 | units on a scale | |
| Mean Change From Baseline to Week 5 in Average Daily Pain Score (ADPS) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 10 mg QD | -2.32 | Standard Deviation 2.17 | units on a scale | |
| Mean Change From Baseline to Week 5 in Average Daily Pain Score (ADPS) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 15 mg QD | -2.66 | Standard Deviation 2.37 | units on a scale | |
| Mean Change From Baseline to Week 5 in Average Daily Pain Score (ADPS) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 10 mg BID | -2.64 | Standard Deviation 2.45 | units on a scale | |
| Mean Change From Baseline to Week 5 in Average Daily Pain Score (ADPS) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 15 mg BID | -2.79 | Standard Deviation 2.43 | units on a scale | |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | Placebo | Week 1 | -0.55 | 95% Confidence Interval -0.81 to -0.29 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | Pregabalin 150 mg BID | Week 1 | -1.10 | 95% Confidence Interval -1.49 to -0.72 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 5mg QD | Week 1 | -0.68 | 95% Confidence Interval -1.04 to -0.31 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 10 mg QD | Week 1 | -0.95 | 95% Confidence Interval -1.31 to -0.58 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 15 mg QD | Week 1 | -1.13 | 95% Confidence Interval -1.51 to -0.75 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 10 mg BID | Week 1 | -1.26 | 95% Confidence Interval -1.62 to -0.89 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 15 mg BID | Week 1 | -1.40 | 95% Confidence Interval -1.76 to -1.04 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | Placebo | Week 2 | -1.12 | 95% Confidence Interval -1.47 to -0.77 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | Pregabalin 150 mg BID | Week 2 | -1.75 | 95% Confidence Interval -2.26 to -1.24 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 5mg QD | Week 2 | -1.38 | 95% Confidence Interval -1.86 to -0.89 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 10 mg QD | Week 2 | -1.56 | 95% Confidence Interval -2.04 to -1.07 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 15 mg QD | Week 2 | -1.76 | 95% Confidence Interval -2.28 to -1.25 | units on a scale |
| Least Square Means of Average Daily Pain Score by Week Mixed Effects Model for Repeated Measures (MMRM) Following Treatment With DS-5565 Compared to Pregabalin and Placebo | DS-5565 10 mg BID | Week 2 | -1.72 | 95% Confidence Interval -2.20 to -1.23 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01496365/results